METMetLife
Is the price fair?
At the top of its own P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Expensive vs its own history: P/E 18.9 vs a 10.3 median over 37 quarters (+84% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What MET's price assumes
MetLife trades at 18.9× earnings against 14.2× for the median Insurance - Life name, more expensive than its own group.
Trailing P/E · Insurance - Life median 14.2 · 1.33× the median: the market pays up for this one
- Price / sales
- 0.69
Price / sales · as of 2026-Q2
- Price / book
- 1.99
Price / book · as of 2026-Q2
- EV / sales
- 0.53
EV / sales
Details›
- Price / bookas of 2026-Q2
- 1.99
- EV / salesas of 2026-Q2
- 0.53
- Financial Services median P/E599 names
- 12.5
- Insurance - Life median P/E15 names
- 14.2
- Market capitalisation635.5 million shares, counted Jul 31, 2026
- $62.8B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $36.64 |
| Its own P/E history, median | $53.76 |
| Its own P/E history, upper quartile | $79.36 |
| 52-week range | $67.19 – $103.54 |
| Today | $98.80 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
Insurance, Life
The closest names by size in the same industry